WallStreetZenWallStreetZen

NASDAQ: TSHA
Taysha Gene Therapies Inc Stock Ownership - Who owns Taysha Gene Therapies?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Taysha Gene Therapies Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Kamran AlamCHIEF FINANCIAL OFFICER2026-02-041,655$4.52
$7.48kSell
Sean P. NolanChief Executive Officer2026-01-2641,312$4.61
$190.45kSell
Kamran AlamCHIEF FINANCIAL OFFICER2026-01-2623,849$4.61
$109.94kSell
Sukumar NagendranPresident and Head of RD2026-01-2626,918$4.61
$124.09kSell
Sean P. NolanChief Executive Officer2026-01-23136,789$4.75
$649.75kSell
Sukumar NagendranPresident and Head of RD2026-01-2389,132$4.75
$423.38kSell
Kamran AlamCHIEF FINANCIAL OFFICER2026-01-2378,968$4.75
$375.10kSell
Sukumar NagendranPresident and Head of RD2026-01-12200,000$4.71
$942.00kSell
Sukumar NagendranPresident and Head of RD2026-01-1288,676$1.71
$151.64kBuy
Sukumar NagendranPresident and Head of RD2026-01-12111,324$0.70
$77.82kBuy

1 of 2

TSHA insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when TSHA insiders and whales buy or sell their stock.

TSHA Shareholders

What type of owners hold Taysha Gene Therapies Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Ra Capital Management LP8.20%23,555,648$105.29MInstitution
Avoro Capital Advisors LLC7.55%21,700,000$97.00MInstitution
Blackrock Inc6.49%18,643,129$83.33MInstitution
Morgan Stanley6.29%18,078,518$80.81MInstitution
Rtw Investments LP5.71%16,398,297$73.30MInstitution
Vestal Point Capital LP4.79%13,750,000$61.46MInstitution
Goldman Sachs Group Inc 14.77%13,692,739$61.21MInstitution
Goldman Sachs Group Inc4.77%13,692,739$61.21MInstitution
Fmr LLC4.71%13,528,366$60.47MInstitution
Vanguard Group Inc4.62%13,267,805$59.31MInstitution

1 of 3

TSHA vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
TSHA89.42%10.58%Net BuyingNet Selling
ATAI15.24%25.29%Net BuyingNet Buying
BHVN78.77%15.74%Net BuyingNet Selling
ORIC84.83%15.17%Net SellingNet Selling
OLMA78.20%21.80%Net SellingNet Selling
View Top Biotech Stocks

Taysha Gene Therapies Stock Ownership FAQ

Who owns Taysha Gene Therapies?

Taysha Gene Therapies (NASDAQ: TSHA) is owned by 93.61% institutional shareholders, 11.08% Taysha Gene Therapies insiders, and 0.00% retail investors. Ra Session Ii is the largest individual Taysha Gene Therapies shareholder, owning 9.01M shares representing 3.14% of the company. Ra Session Ii's Taysha Gene Therapies shares are currently valued at $40.29M.

If you're new to stock investing, here's how to buy Taysha Gene Therapies stock.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.